NUWE.NASDAQNuwellis, INC

Form 4: Nuwellis Director Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Director Archelle Georgiou Feldshon acquired 17,496 nonstatutory stock options in Nuwellis, Inc. on May 20, 2025.

Summary

  • On May 20, 2025, Archelle Georgiou Feldshon, a director of Nuwellis, Inc., acquired 17,496 nonstatutory stock options.
  • The exercise price of these options is $0.9558.
  • The options vest in 12 approximately equal monthly increments, starting one month after the grant date, and will be fully vested after one year.
  • The expiration date for these options is May 19, 2035.
  • Following the transaction, Feldshon directly owns 17,496 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to a director, which doesn't inherently indicate positive or negative sentiment.

Positives

  • A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into insider transactions.

Stakeholder Impact

  • The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
05/20/2025Date of transaction: Archelle Georgiou Feldshon acquired stock options.
05/21/2025Date of Form 4 filing.
05/19/2035Expiration date of the nonstatutory stock options.

Keywords

stock options, Form 4, director, Nuwellis, NUWE, acquisition, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.